Search research articles
Contact Us
Filters
Showing results (271-280 of 632) with videos related to
Page
of 64
Sort By:
Frontiers in Medicine
|
March 16, 2026
Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: insights from a 6-year retrospective cohort study
Nicole Anna Dietzel, Maria Schmidt, Johannes Wiegand, et al.
The Journal of Infectious Diseases
|
May 10, 2018
Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B
Florian van Bömmel, Alena van Bömmel, Alexander Krauel, et al.
Pharmacogenetics and Genomics
|
February 25, 2011
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C
Alexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
BMC Gastroenterology
|
April 22, 2017
Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality
Thorsten Kaiser, Benedict Kinny-Köster, Michael Bartels, et al.
Plos One
|
March 24, 2017
Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis
Susen Becker, Benedict Kinny-Köster, Michael Bartels, et al.
Plos One
|
June 23, 2026
Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD
Eva Katharina Messer, Janett Fischer, Toni Herta, et al.
Seminars in Liver Disease
|
May 15, 2021
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure
Cornelius Engelmann, Vincent Di Martino, Annarein J C Kerbert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 1, 2007
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin
Eric Snoeck, Stephanos J Hadziyannis, Claudio Puoti, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2023
Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians
Janett Fischer, Eleni Koukoulioti, Tobias Müller, et al.
Zeitschrift Fur Gastroenterologie
|
September 9, 2024
Pia Lorenz, Niklas Aehling, Tony Bruns, et al.
Page
of 64
Search research articles
Search
Showing results (271-280 of 632) with videos related to
Sort By:
Page
of 64
Frontiers in Medicine
|
March 16, 2026
Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: insights from a 6-year retrospective cohort study
Nicole Anna Dietzel, Maria Schmidt, Johannes Wiegand, et al.
The Journal of Infectious Diseases
|
May 10, 2018
Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B
Florian van Bömmel, Alena van Bömmel, Alexander Krauel, et al.
Pharmacogenetics and Genomics
|
February 25, 2011
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C
Alexandra Doehring, Wolf Peter Hofmann, Christina Schlecker, et al.
BMC Gastroenterology
|
April 22, 2017
Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality
Thorsten Kaiser, Benedict Kinny-Köster, Michael Bartels, et al.
Plos One
|
March 24, 2017
Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis
Susen Becker, Benedict Kinny-Köster, Michael Bartels, et al.
Plos One
|
June 23, 2026
Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD
Eva Katharina Messer, Janett Fischer, Toni Herta, et al.
Seminars in Liver Disease
|
May 15, 2021
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure
Cornelius Engelmann, Vincent Di Martino, Annarein J C Kerbert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 1, 2007
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin
Eric Snoeck, Stephanos J Hadziyannis, Claudio Puoti, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2023
Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians
Janett Fischer, Eleni Koukoulioti, Tobias Müller, et al.
Zeitschrift Fur Gastroenterologie
|
September 9, 2024
Pia Lorenz, Niklas Aehling, Tony Bruns, et al.
Page
of 64